Russell Frank Company’s Calithera Biosciences, Inc CALA Stock Holding History

Russell Frank Company’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$267K	Buy	+2,350	New	+$266K	﹤0.01%	2625

Other funds holding CALA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MMPI

Morgenthaler Management Partners IX Portola Valley, California $22.6M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Russell Frank Company's CALA Position: Q1 2016 in Review

Russell Frank Company opened a new position in Calithera Biosciences, Inc (CALA) in Q1 2016: 2,350 shares worth $267K. The stake represents ﹤0.01% of the portfolio and ranks #2625 among its holdings.

52 funds tracked by Wall St. Rank hold CALA as of Q1 2016.

Russell Frank Company held 2,350 shares of Calithera Biosciences, Inc worth $267K as of Q1 2016.
Calithera Biosciences, Inc was a new Russell Frank Company position in Q1 2016.
Calithera Biosciences, Inc made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2625 holding.
52 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.